Gastroesophageal Adenocarcinoma Recruiting Phase 1 / 2 Trials for Guaifenesin (DB00874)

IndicationStatusPhase
DBCOND0030813 (Gastroesophageal Adenocarcinoma)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs